A. Partin

714 total citations
18 papers, 562 citations indexed

About

A. Partin is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, A. Partin has authored 18 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 4 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in A. Partin's work include Prostate Cancer Diagnosis and Treatment (13 papers), Prostate Cancer Treatment and Research (13 papers) and Urologic and reproductive health conditions (2 papers). A. Partin is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (13 papers), Prostate Cancer Treatment and Research (13 papers) and Urologic and reproductive health conditions (2 papers). A. Partin collaborates with scholars based in United States, Austria and Germany. A. Partin's co-authors include Jeffrey A. Cadeddu, Theodore L. DeWeese, Steven R. Potter, Jürgen Pannek, Georg Bartsch, Michael A. Carducci, Martina Tinzl, D. Albala, Truls E. Bjerklund Johansen and Ashley E. Ross and has published in prestigious journals such as The Journal of Urology, Urology and Prostate Cancer and Prostatic Diseases.

In The Last Decade

A. Partin

17 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Partin United States	9	443	136	135	123	86	18	562
Thomas H. Douglas United States	10	411 0.9×	81 0.6×	70 0.5×	69 0.6×	63 0.7×	12	503
Boon Kua Australia	13	527 1.2×	73 0.5×	123 0.9×	71 0.6×	63 0.7×	24	592
CHERYL M. YEMOTO United States	7	561 1.3×	66 0.5×	191 1.4×	71 0.6×	100 1.2×	9	616
Alan W Partin United States	8	483 1.1×	80 0.6×	192 1.4×	56 0.5×	72 0.8×	8	560
Meryem Brihoum France	8	414 0.9×	47 0.3×	50 0.4×	68 0.6×	67 0.8×	12	470
Per Å. Høisæter Norway	12	289 0.7×	79 0.6×	89 0.7×	60 0.5×	50 0.6×	28	455
Vijaya A. Bhadkamkar United States	7	395 0.9×	53 0.4×	108 0.8×	28 0.2×	73 0.8×	8	471
K.C. Dallow United States	6	471 1.1×	21 0.2×	94 0.7×	31 0.3×	78 0.9×	9	504
J.D. Forman United States	9	274 0.6×	52 0.4×	35 0.3×	74 0.6×	34 0.4×	23	358
Bernhard Grubmüller Austria	12	615 1.4×	109 0.8×	52 0.4×	81 0.7×	40 0.5×	33	681

Countries citing papers authored by A. Partin

Since Specialization

Citations

This map shows the geographic impact of A. Partin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Partin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Partin more than expected).

Fields of papers citing papers by A. Partin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Partin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Partin. The network helps show where A. Partin may publish in the future.

Co-authorship network of co-authors of A. Partin

This figure shows the co-authorship network connecting the top 25 collaborators of A. Partin. A scholar is included among the top collaborators of A. Partin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Partin. A. Partin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Mouraviev, Vladimir, D. Albala, Truls E. Bjerklund Johansen, et al.. (2015). Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer. Prostate Cancer and Prostatic Diseases. 19(1). 14–20. 79 indexed citations

Bastian, Patrick J., Mark L. Gonzalgo, Leslie A. Mangold, et al.. (2006). RELATIONSHIP BETWEEN PRIMARY GLEASON PATTERN ON NEEDLE BIOPSY AND CLINICOPATHOLOGICAL OUTCOMES AMONG MEN WITH GLEASON 7 ADENOCARCINOMA OF THE PROSTATE. European Urology Supplements. 5(2). 315–315. 1 indexed citations

Bartsch, Georg, M K Brawer, Carol D Cheli, et al.. (2003). Predicting cancer on repeat biopsy: Results of a multicenter prospective evaluation of complexed PSA. European Urology Supplements. 2(1). 183–183. 2 indexed citations

Khan & A. Partin. (2003). EVALUATION OF PSA FOR EARLY DETECTION OF PROSTATIC CANCER IN MEN. 170(3). 723–726. 1 indexed citations

Pannek, Jürgen & A. Partin. (2002). Untersuchungen zur unterschiedlichen Karzinominzidenz von Prostata und Samenblasen. Aktuelle Urologie. 33(3). 206–212. 2 indexed citations

Roberts, William W., Erik J. Bergstralh, Michael L. Blute, et al.. (2001). Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy. Urology. 57(6). 1033–1037. 69 indexed citations

Epstein, Jonathan I., et al.. (2001). The role of prostate needle biopsy in evaluation of chemopreventive agents. Urology. 57(4). 191–193. 4 indexed citations

Potter, Steven R., et al.. (2001). Age, prostate-specific antigen, and digital rectal examination as determinants of the probability of having prostate cancer. Urology. 57(6). 1100–1104. 59 indexed citations

Potter, Steven R., et al.. (2000). The role of free prostate-specific antigen in prostate cancer detection. Current Urology Reports. 1(1). 78–82. 8 indexed citations

10.

Lee, Chung, G.P. Murphy, Saad Khoury, A. Partin, & L. Denis. (2000). Prostate Cancer, 2nd International consultation on Prostate Cancer. 4 indexed citations

11.

Potter, Steven R. & A. Partin. (1999). Prostate cancer: Detection, staging, and treatment of localized disease. Seminars in Roentgenology. 34(4). 269–283. 5 indexed citations

12.

Carducci, Michael A., Charles R. Pound, Jonathan I. Epstein, et al.. (1999). Nuclear morphometry adds significant prognostic information to stage and grade for renal cell carcinoma. Urology. 53(1). 44–49. 36 indexed citations

13.

Epstein, Jonathan I., et al.. (1999). Influence of Age and Prostate-Specific Antigen on the Chance of Curable Prostate Cancer Among Men With Nonpalpable Disease. The Journal of Urology. 162(1). 266–266. 5 indexed citations

14.

Cadeddu, Jeffrey A., et al.. (1998). LONG-TERM RESULTS OF RADIATION THERAPY FOR PROSTATE CANCER RECURRENCE FOLLOWING RADICAL PROSTATECTOMY. The Journal of Urology. 159(1). 173–178. 167 indexed citations

15.

Pannek, Jürgen & A. Partin. (1998). The role of PSA and percent free PSA for staging and prognosis prediction in clinically localized prostate cancer.. PubMed. 16(3). 100–5. 28 indexed citations

16.

Page, William F., M. Miles Braun, A. Partin, N Caporaso, & Patrick Paul Walsh. (1998). Heredity and Prostate Cancer: A Study of World War II Veteran Twins. The Journal of Urology. 160(1). 264–264.

17.

Carter, H. Ballentine, A. Partin, Albert A. Luderer, et al.. (1997). Percentage of free prostate-specific antigen in sera predicts aggressiveness of prostate cancer a decade before diagnosis. Urology. 49(3). 379–384. 74 indexed citations

18.

Walsh, Patrick C. & A. Partin. (1994). Treatment of early stage prostate cancer: radical prostatectomy.. PubMed. 211–23. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact